Pfizer stock heads into Q3 report with a lower earnings bar


Pfizer stock heads into November 3 results with lower consensus ...

Pfizer stock: ELREXFIO trial win adds to oncology momentum ...

Pfizer stock gains as ELREXFIO win strengthens oncology ...

Pfizer reports ELREXFIO trial success while Pfizer stock ...

Jefferies keeps a USD 36.00 target for Pfizer stock

Pfizer expands TALZENNA approval. Pfizer stock stands 1.81 ...

Pfizer stock stands 3.97 percent above USD 28.72 consensus ...

Pfizer reports 25-valent vaccine data. November 3 results ...

Pfizer Inc. stock lists analyst webcast November 3 2026 ...